Regorafenib 40 mg Tablets are an oral targeted cancer medicine containing regorafenib, a multikinase inhibitor used under specialist medical supervision for certain advanced or metastatic cancers. Regorafenib is used in adults with conditions including metastatic colorectal cancer (CRC), gastrointestinal stromal tumours (GIST), and hepatocellular carcinoma (HCC), depending on treatment history and local prescribing guidance.
Cordium Pharmaceuticals Pvt Ltd, an India-based pharmaceutical exporter, supports international supply requirements for Regorafenib 40 mg Tablets for eligible healthcare and pharmaceutical buyers.
Regorafenib 40 mg Tablets – Key Uses
Regorafenib may be prescribed for:
Metastatic colorectal cancer
Unresectable or metastatic GIST
Hepatocellular carcinoma after previous sorafenib treatment
Treatment eligibility depends on the patient's diagnosis, previous therapies, medical history, and the prescribing physician's assessment.
Regorafenib 40 mg Dosage
The standard labelled regimen for many adult patients is 160 mg once daily (four 40 mg tablets) for 21 days, followed by 7 days without treatment, forming a 28-day cycle. Doctors may reduce or interrupt the dose depending on tolerability and adverse effects.
Regorafenib is a prescription cancer medicine. Do not start, stop, or change the dosage without guidance from an oncology specialist.
Regorafenib 40 mg Tablets Supply in UAE, UK & South Africa
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical sourcing and export support for Regorafenib 40 mg Tablets for authorized buyers, including:
UAE: Dubai, Abu Dhabi and other locations
UK: London, Manchester, Birmingham and other locations
South Africa: Johannesburg, Cape Town, Durban and other locations
Availability, import requirements, prescription requirements, and regulatory conditions can differ between countries. Buyers should ensure compliance with applicable local pharmaceutical regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Pharmaceutical export support from India
International sourcing assistance
Supply for authorized pharmaceutical buyers
Support for hospitals, pharmacies and distributors
Documentation and shipping coordination
International delivery support
Frequently Asked Questions
What is Regorafenib 40 mg?
Regorafenib 40 mg is an oral tablet containing 40 mg of regorafenib, a targeted anticancer medicine.
What is Regorafenib used for?
It is used for certain advanced or metastatic colorectal cancers, GIST and hepatocellular carcinoma in appropriate adult patients.
How is Regorafenib generally taken?
A commonly recommended regimen is 160 mg once daily for 21 days followed by a 7-day break, although the treating physician may modify the regimen.
Is Regorafenib available in the UAE, UK and South Africa?
Cordium Pharmaceuticals Pvt Ltd can assist eligible buyers with international sourcing and export enquiries, subject to applicable regulations and product availability.
Is Regorafenib prescription-only?
Yes. Regorafenib should be used under appropriate medical supervision.
For Regorafenib 40 mg Tablets export and supply enquiries, contact Cordium Pharmaceuticals Pvt Ltd for product availability, quotation and international shipping assistance.
